IFR International - 20.10.2018

As well as grappling with the negatives from Sarwa, there is also pessimism in London following several IPO cancellations and ot ...

The offering is backed with US$30m insider support, including Novartis Pharma. Novartis is Gamida’s largest shareholder with a 2 ...

which launched following a wall-crossing process that focused mostly on local INVESTORSû4HEREûWASûSUFlCIENTûDEMANDûFORû sole bo ...

The capital increase is fully underwritten with the risk split equally between joint bookrunners Morgan Stanley and UBS. UK SMIT ...

Even though tech stocks recovered some ground earlier in the week, EPAM fell as much as 11% during this period, Globant declined ...

INTENDSûTOûlLEûANûINVESTIGATIONALûNEWûDRUGû application and initiate a Phase I trial in human patients by the end of next year. ...

ûmOWûBACKûTOû%ARLY"IRDvûONEû30!#û banker told IFR. “We have seen jump-ball back-ends up to two-thirds. [EarlyBird] makes it ...

SolarWinds’ public comps Red Hat, Atlassian and Splunk came under pressure during the marketing of the IPO, their share prices f ...

Falabella last week from Ps4,300 to Ps5,000 but maintained an underperform rating on the stock. “We believe the main upside risk ...

Start the week with IFR’s Capital Markets Week Ahead email: a brief, global, cross-asset class look at the key capital markets d ...

INTERNATIONAL FINANCING REVIEW CONTACTSINTERNATIONAL FINANCING REVIEW CONTACTS LONDON, HEAD OFFICE 30 South Colonnade Canary Wha ...

IFR ASIA: AT THE HEART OF ASIA’S CAPITAL MARKETS IFR Asia is the world’s most authoritative source of Asian capital markets inte ...

INTERNATIONAL FINANCING REVIEW INDEX 21st Century Fox 4 Aclaris Therapeutics 86 Aegon 30 AEON REIT Investment 61 Aetna 59 Agilit ...

...